Hartmut Schirok

1.5k total citations
33 papers, 1.0k citations indexed

About

Hartmut Schirok is a scholar working on Organic Chemistry, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hartmut Schirok has authored 33 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Organic Chemistry, 16 papers in Molecular Biology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hartmut Schirok's work include Nitric Oxide and Endothelin Effects (6 papers), Catalytic C–H Functionalization Methods (5 papers) and Synthesis and Reactivity of Heterocycles (5 papers). Hartmut Schirok is often cited by papers focused on Nitric Oxide and Endothelin Effects (6 papers), Catalytic C–H Functionalization Methods (5 papers) and Synthesis and Reactivity of Heterocycles (5 papers). Hartmut Schirok collaborates with scholars based in Germany, United States and China. Hartmut Schirok's co-authors include Lutz F. Tietze, Joachim Mittendorf, Johannes‐Peter Stasch, Cristina Alonso‐Alija, Alexander Straub, Nils Griebenow, Markus Follmann, Martin Michels, Martina Schäfer and Friederike Stoll and has published in prestigious journals such as Journal of the American Chemical Society, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Hartmut Schirok

33 papers receiving 982 citations

Peers

Hartmut Schirok

PHYSI

CCM

PRM

Stéphane De Lombaert United States

Martin Winn United States

Ingo V. Hartung Germany

Jeremy J. Edmunds United States

Andrew S. Tasker United States

Michael Gerisch Germany

Hélène Jûteau Canada

Kennan Marsh United States

Ka Young Lee South Korea

Bryan K. Sorensen United States

Stéphane De Lombaert United States

Hartmut Schirok

599 ×1.2

362 ×1.0

166 ×0.9

PHYSI

138 ×1.1

CCM

78 ×0.6

PRM

Citations per year, relative to Hartmut Schirok Hartmut Schirok (= 1×) peers Stéphane De Lombaert

Countries citing papers authored by Hartmut Schirok

Since Specialization

Citations

This map shows the geographic impact of Hartmut Schirok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hartmut Schirok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hartmut Schirok more than expected).

Fields of papers citing papers by Hartmut Schirok

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hartmut Schirok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hartmut Schirok. The network helps show where Hartmut Schirok may publish in the future.

Co-authorship network of co-authors of Hartmut Schirok

This figure shows the co-authorship network connecting the top 25 collaborators of Hartmut Schirok. A scholar is included among the top collaborators of Hartmut Schirok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hartmut Schirok. Hartmut Schirok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Herbert, Simon A., et al.. (2024). Synthesis of 1,2-Benzothiazine via Nickel-Catalyzed Electrochemical Intramolecular Amination. Organic Letters. 26(42). 9034–9039. 3 indexed citations

Liu, Dong, Zhenhua Wang, Cong Ma, et al.. (2022). Paired electrolysis-enabled nickel-catalyzed enantioselective reductive cross-coupling between α-chloroesters and aryl bromides. Nature Communications. 13(1). 7318–7318. 75 indexed citations

Duh, Elia J., Marcus Karlstetter, Zhenhua Xu, et al.. (2018). Evaluation of a new pharmacologic strategy for Nrf2 activation for retinal ischemia-reperfusion injury. 59(9). 3203–3203. 1 indexed citations

Follmann, Markus, Nils Griebenow, Michael G. Hahn, et al.. (2013). The Chemistry and Biology of Soluble Guanylate Cyclase Stimulators and Activators. Angewandte Chemie International Edition. 52(36). 9442–9462. 159 indexed citations

Griebenow, Nils, Hartmut Schirok, Joachim Mittendorf, et al.. (2013). Identification of acidic heterocycle-substituted 1H-pyrazolo[3,4-b]pyridines as soluble guanylate cyclase stimulators. Bioorganic & Medicinal Chemistry Letters. 23(5). 1197–1200. 10 indexed citations

Longo, Sharon L., David J Padalino, Sandra L. B. McGillis, et al.. (2011). Bay846, a new irreversible small molecule inhibitor of EGFR and Her2, is highly effective against malignant brain tumor models. Investigational New Drugs. 30(6). 2161–2172. 8 indexed citations

Dahal, Bhola K., Djuro Kosanovic, Akylbek Sydykov, et al.. (2010). Therapeutic efficacy of azaindole-1 in experimental pulmonary hypertension. European Respiratory Journal. 36(4). 808–818. 44 indexed citations

Mittendorf, Joachim, Stefan Weigand, Cristina Alonso‐Alija, et al.. (2009). Discovery of Riociguat (BAY 63‐2521): A Potent, Oral Stimulator of Soluble Guanylate Cyclase for the Treatment of Pulmonary Hypertension. ChemMedChem. 4(5). 853–865. 145 indexed citations

Mittendorf, Joachim, Stefan Weigand, Cristina Alonso‐Alija, et al.. (2009). Discovery of riociguat (BAY 63-2521): a potent, oral stimulator of soluble guanylate cyclase for the treatment of pulmonary hypertension. BMC Pharmacology. 9(S1). 2 indexed citations

10.

Schirok, Hartmut, Raimund Kast, Santiago Figueroa‐Pérez, et al.. (2008). Design and Synthesis of Potent and Selective Azaindole‐Based Rho Kinase (ROCK) Inhibitors. ChemMedChem. 3(12). 1893–1904. 35 indexed citations

11.

Kast, R., Hartmut Schirok, Santiago Figueroa‐Pérez, et al.. (2007). Cardiovascular effects of a novel potent and highly selective azaindole‐based inhibitor of Rho‐kinase. British Journal of Pharmacology. 152(7). 1070–1080. 56 indexed citations

12.

Schirok, Hartmut, et al.. (2007). Synthesis and Derivatization of 3‐Perfluoroalkyl‐Substituted 7‐Azaindoles.. ChemInform. 38(20). 1 indexed citations

13.

Schirok, Hartmut. (2006). Microwave-Assisted Flexible Synthesis of 7-Azaindoles. The Journal of Organic Chemistry. 71(15). 5538–5545. 33 indexed citations

14.

Schirok, Hartmut. (2005). A Versatile Synthesis of 7-Azaindoles. Synlett. 2005(8). 1255–1258. 9 indexed citations

15.

Pernerstorfer, Josef, et al.. (2004). Solid phase synthesis of an extensively focused library of thiadiazole ethers. Tetrahedron. 60(39). 8627–8632. 3 indexed citations

16.

Trost, Barry M., Hong C. Shen, Tobias Schulz, Christopher Koradin, & Hartmut Schirok. (2003). On the Diastereoselectivity of Ru-Catalyzed [5 + 2] Cycloadditions. Organic Letters. 5(22). 4149–4151. 38 indexed citations

17.

Tietze, Lutz F., et al.. (2000). Palladium-Catalyzed Synthesis of Cephalotaxine Analogues. Chemistry - A European Journal. 6(3). 510–518. 18 indexed citations

18.

Tietze, Lutz F. & Hartmut Schirok. (1999). Enantioselective Highly Efficient Synthesis of (−)-Cephalotaxine Using Two Palladium-Catalyzed Transformations. Journal of the American Chemical Society. 121(44). 10264–10269. 82 indexed citations

19.

Tietze, Lutz F. & Hartmut Schirok. (1997). Highly Efficient Synthesis of Cephalotaxine by Two Palladium‐Catalyzed Cyclizations. Angewandte Chemie International Edition in English. 36(10). 1124–1125. 47 indexed citations

20.

Tietze, Lutz F. & Hartmut Schirok. (1997). Hocheffiziente Synthese von Cephalotaxin durch zweifache palladiumkatalysierte Cyclisierung. Angewandte Chemie. 109(10). 1159–1160. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact